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Abstract
 
Macrophages exposed to macrophage colony-stimulating factor acquire the capacity to suppress
T cell proliferation; this effect is associated with de novo expression of the tryptophan-catabo-
lizing enzyme indoleamine 2,3-dioxygenase (IDO). We have purified IDO and tested its activ-
ity in in vitro models of T cell activation. IDO was able to inhibit proliferation of CD4
 
 
 
 T
lymphocytes, CD8
 
 
 
 T lymphocytes, and natural killer (NK) cells; proliferation of B lympho-
cytes was not affected. The inhibitory role of tryptophan and of its catabolites was then tested.
In the presence of tryptophan, only 
 
L
 
-kynurenine and picolinic acid inhibit cell proliferation.
In a tryptophan-free medium cell proliferation was not affected. In the absence of tryptophan
inhibition induced by 
 
L
 
-kynurenine and picolinic acid was observed at concentrations below
the lowest concentration that was effective in the presence of tryptophan, and quinolinic acid
acquired some inhibitory capacity. Inhibition of cell proliferation induced by the tryptophan
catabolites resulting from IDO activity was selective, applying only to cells undergoing activa-
tion. Resting cells were not affected and could subsequently activate normally. We suggest that
IDO exerts its effect on cell proliferation by (i) starting the cascade of biochemical reactions
that produce the three catabolites and by (ii) enhancing their inhibitory potential by depriving
the extracellular microenvironment of tryptophan.
Key words: T cell proliferation • macrophages • indoleamine 2,3-dioxygenase • tryptophan • 
kynurenine
 
Introduction
 
Indoleamine 2,3-dioxygenase (IDO)
 
*
 
 is an enzyme, ubiq-
uitously distributed in mammalian tissues and cells, con-
verting tryptophan to 
 
N
 
-formylkynurenine. This substance
is further catabolized to kynurenine and then to the termi-
nal metabolites picolinic acid or quinolinic acid.
Evidences gathered in the last 10 y indicate that this en-
zyme functions as an antimicrobial defense mechanism by
allowing cells to deplete tryptophan from intracellular pool
or local microenvironment (1). Enhanced IDO activity was
also found in vitro upon cell stimulation with Th1 type cy-
tokines, and in vivo in diseases that are associated with
chronic stimulation of Th1-mediated immunity (2).
Furthermore, a new role for IDO as immunosuppres-
sive agent has been recently suggested (3). The authors
provided evidence that expression of IDO during murine
pregnancy could be instrumental in preventing rejection
of the semiallogeneic fetus (4, 5). Further in vitro studies
showed that monocyte-derived macrophages exposed to
macrophage colony-stimulating factor (MCSF) acquire
the capacity to suppress T cell proliferation by arresting T
cells in the mid-G1 phase of the cell cycle (6). This effect
is associated with de novo expression of IDO and with
reduction of tryptophan concentration in the medium
and can be prevented by IDO inhibitors (6). However,
the demonstration that immunosuppression is achieved in
this model solely by means of the IDO activity, and solely
by means of the selective depletion of tryptophan is
largely indirect. Furthermore, the analysis of the effects of
tryptophan-derived catabolites on T cell proliferation is
lacking (2).
Only the availability of purified IDO could allow to pre-
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cisely identify the effects of the enzyme, and to elucidate
the role played in this frame by the levels of tryptophan and
of its catabolites in the extracellular environment.
 
Materials and Methods
 
IDO Purification.
 
The enzyme was purified following previ-
ously described techniques with major modifications (7).
 
Step 1: Crude Extract
 
. Small intestine from 60 rabbits weighing
 
 
 
2 kg was provided by a breeding farm (A.R.C.E., Montemozzo
di Temossi, Genoa, Italy). The distal 40-cm portion was cut lon-
gitudinally, luminal contents were accurately washed out with ice
cold 0.9% NaCl solution, the intestine was cut in small pieces
with a blade, and 200 g aliquots were then frozen at 
 
 
 
80
 
 
 
C.
When necessary, 300 ml of 50 mM phosphate buffer, pH 6.0,
supplemented with 2 mM 4-(2-aminoethyl)-benzenesulfonyl flu-
oride, 10 
 
 
 
g/ml leupeptine and 10 
 
 
 
g/ml pepstatine (all from
Sigma-Aldrich) were added to an aliquot. All subsequent proce-
dures were performed at 4
 
 
 
C. The sample was then minced with
a food blender, and lysis of tissue was completed using a Potter-
Elvehjem homogenizer.
 
Step 2: Ammonium Sulfate Fractionation
 
. After centrifugation at
20,000 
 
g
 
 for 35 min, supernatant was collected and solid ammo-
nium sulfate was added slowly with stirring till 70% of the saturat-
ing concentration was reached. The solution was stirred for 1
more hour, then the precipitate was recovered by centrifuging at
10,000 
 
g
 
 for 10 min. Afterward, 30 ml ammonium sulfate at 50%
of the saturating concentration were added to the precipitate,
which was suspended with a Potter-Elvehjem homogenizer, and
supernatant was collected. This procedure was repeated two more
times, then the pooled supernatants were dialized against 50 mM
phosphate buffer, pH 6.0.
 
Step 3: Hydroxyapatite Chromatography
 
. 100 ml Bio-Gel hy-
droxyapatite (Bio-Rad Laboratories), rehydrated with 50 mM
phosphate buffer, pH 6.0, were poured in a 2 
 
 
 
 40 cm column.
After loading the sample, the column was washed with 50 mM
phosphate buffer, pH 6.0, and then a linear gradient elution was
performed between 200 ml each of 150 and 500 mM phosphate
buffer, pH 6.0. Fractions between 240 and 340 mM phosphate
concentration were pooled, and concentrated to 9 ml with Ami-
con YM-10 membrane (Amicon).
 
Step 4: Gel Filtration on Sephadex G-100
 
. 4.5 ml of the sample
were applied on a 3 
 
 
 
 50 cm column of Sephadex G-100 (Amer-
sham Pharmacia Biotech) column previously equilibrated with 150
mM KCl in 20 mM phosphate buffer, pH 6.0. Blue Dextran and
Xylene Cyanole were used as molecular weight markers: down-
ward elution at a flow rate of 0.5 ml/min was performed using the
same buffer, and fractions in between the two markers were col-
lected. Fractions having a ratio of absorbance at 406 nm to absor-
bance at 280 above 0.4 and displaying IDO activity were pooled
and concentrated to 3 ml with Amicon YM-10 membrane.
 
Step 5: Blue Sepharose Chromatography
 
. 1 g of Blue Sepharose
CL-6B powder (Amersham Pharmacia Biotech) was rehydrated
with distilled water, loaded in a 20-cm column and equilibrated
with 20 mM phosphate buffer, pH 6.0. The same buffer was
used to dilute 1:10 the sample, then the solution was loaded on
the column. After washing, a linear gradient elution was per-
formed between 20 ml each of 20 mM phosphate buffer, pH 6.0,
and 1 M KCl in 20 mM phosphate buffer, pH 6.0, at a flow rate
of 0.4 ml/min. Ratio of absorbance at 406 nm to absorbance at
280 nm was evaluated for each fraction, and the fractions having
a value 
 
 
 
1.0 were pooled and concentrated to 140 
 
 
 
l with Am-
icon YM-10 membrane, followed by Centricon 10 (Amicon) ul-
trafiltration.
Purity of the sample was checked by SDS-PAGE, followed by
Coomassie Blue staining, and by HPLC, using a TSK gel
G3000SW (Toso Haas) gel filtration column.
The protein amount was evaluated by Bradford (8) method
(Bradford Anal Biochem) using BSA as standard. The purified
enzyme was stored in aliquots at 
 
 
 
80
 
 
 
C at concentrations 
 
 
 
3
mg/ml.
 
Assay of IDO.
 
The reaction was performed exactly following
a technique described previously (9). The amount of L-kynure-
nine in the supernatant was measured by reversed phase HPLC
(HP 1090; Hewlett-Packard), using a 
 
 
 
-Bondapack with C-18
column (10 
 
 
 
 30 mm, 5-
 
 
 
m particle size; Waters). 1 U of the
enzyme activity was defined as the amount that produced 1 nmol
of Kynurenine/h.
 
Cell Isolation and Culture.
 
Heparinized (heparin 10 U/ml) venous
blood was obtained from healthy male volunteers after informed
consent. PBMCs were isolated by centrifugation on a discontinu-
ous density gradient of Fycoll-Hypaque (Biochrom KG). After-
ward, adherent cells were removed by adherence, and PBLs were
collected.
Isolation of CD4
 
 
 
 and CD8
 
 
 
 T lymphocytes, B lymphocytes,
and NK cells was performed by means of immunomagnetic beads
(IO beads; Immunotech-Coulter), exactly following manufac-
turer’s instructions. Cells were separated by negative selection
from PBLs, using the following murine mAbs: OKT 8 (anti-
CD8; American Type Culture Collection), BU12 (anti-CD19,
purified from the homonymous hybridoma, provided by I.C.M.
MacLennan, University of Birmingham, Birmingham, UK), anti–
human N-CAM (anti-CD56; BioSource), and RMO52 (anti-
CD14; Beckman Coulter) for CD4
 
 
 
 T lymphocytes; OKT 4
(anti-CD4, American Type Culture Collection), BU 12, anti–
human N-CAM, and RMO52 for CD8
 
 
 
 T lymphocytes;
UCHT-1 (anti-CD3, Technogenetics, Cassina de’ Pecchi, Italy),
anti–human N-CAM, and RMO52 for B lymphocytes; and BU
12, UCHT-1, and RMO52 for NK cells. Monocytes to be used
as feeder cells were separated by negative selection from adherent
PBMCs by using BU 12, UCHT-1, and anti–human N-CAM.
Purity was checked by flow cytometry, measuring the mem-
brane expression of CD4, CD8, CD19, CD56, and CD14, re-
spectively.
Only cell preparations with purity 
 
 
 
95% were taken into ac-
count. In some cases a second round of separation was required.
Cells were grown, unless otherwise stated, in RPMI 1640 sup-
plemented with 10% FCS and 2 mM 
 
L
 
-glutamine (all from Bio-
chrom KG).
 
Cell Activation and Proliferation.
 
Cell proliferation studies were
performed, unless otherwise indicated, on restimulated alloreac-
tive T cells and on PHA-activated PBLs. Both models gave
equivalent results; the data shown are from PHA-activated PBLs.
To produce alloreactive T cell lines 10
 
5
 
 PBLs from responder
were incubated with the same amount of irradiated (5,000 rad)
PBLs from stimulator in round bottomed, 96-well plates. The day
after, and every other day, 10 U/ml IL-2 (Chiron BV) were
added. Each alloreactive CD3-positive cell line was maintained by
adding, every 2 wk, 5 
 
 
 
 10
 
4
 
 irradiated PBLs from stimulator. The
addition of irradiated PBLs from stimulator marked the start of
proliferation assays. After 24 and 48 h, 10 U/ml IL-2 were added.
To perform the MLRs indicated in Fig. 9, 1.5 
 
 
 
 10
 
5
 
 PBLs
from responder were incubated with 10
 
5
 
 irradiated (5,000 rad)
PBLs from stimulator in round bottomed, 96-well plates, either
in the absence or in the presence of 500 
 
 
 
M 
 
L
 
-kynurenine. The 
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day after, and every other day, 10 U/ml IL-2 were added. After
5 d supernatant was carefully removed, new medium was added,
and cultures were restimulated with 10
 
5
 
 irradiated PBLs from ei-
ther the original stimulator or from a new stimulator. 6 d after 1
 
 
 
Ci 
 
3
 
[H]thymidine (Amersham Pharmacia Biotech) was added,
and a standard thymidine incorporation assay was performed as
indicated below.
To obtain PHA blasts, 10
 
6
 
 cells/ml PBLs were incubated for 1 h
with PHA M form (Life Technologies) at a final concentration
of 10 
 
 
 
l/ml. Afterward, cells were washed twice and seeded in
round bottomed, 96-well plates at 5 
 
 
 
 10
 
4
 
 cells per well to start
proliferation assays. After 24 and 48 h, 10 U/ml IL-2 were added.
The protocol used to obtain PHA blasts was also used to activate
purified CD4
 
 
 
 T lymphocytes, CD8
 
 
 
 T lymphocytes, and NK
cells. However, for the latter subpopulation changes were made:
NK cells were seeded on a feeder layer of 10
 
5
 
 irradiated autologous
monocytes, and IL-2 was used at a concentration of 20 U/ml.
B lymphocytes were seeded in round bottomed, 96-well plates
at 5 
 
 
 
 10
 
4
 
 cells per well and activated by coincubation with
1:64,000 dilution of Pansorbin cells (Calbiochem). After 24 and
48 h, 10 U/ml IL-2 were added.
When indicated, 0.1 
 
 
 
M methylene blue, 200 
 
 
 
M 
 
L
 
-ascorbic
acid (all from Sigma-Aldrich) or 1 mM 1-methyl-DL-tryptophan
(Sigma-Aldrich) were added at the beginning of the test. These
reagents, at the above mentioned concentrations, did not affect
cell viability, as assessed by trypan blue dye exclusion technique
and by flow cytometric evaluation of cell membrane permeability
to propidium iodide (Sigma-Aldrich). IDO was added at time and
concentrations indicated in the text, in a final volume of 200 
 
 
 
l.
To activate and grow the cells in the absence of tryptophan, a
custom-made tryptophan-free RPMI 1640 medium (Biochrom
KG) was supplemented with 2 mM 
 
L
 
-Glutamine, 1
 
 
 
 nonessen-
tial amino acids (GIBCO BRL, Life Technologies), and 20% dia-
lyzed FCS. Dialysis was performed against 200 volumes of PBS
with 10 changes. The resulting culture medium was devoid of
tryptophan, as detected by the technique described below. Pre-
liminary validation experiments confirmed that T cell prolifera-
tion in this medium was comparable to proliferation in the above
mentioned normal medium. Preliminary tests also demonstrated
that this medium did not affect cell viability.
In some cases 
 
L
 
-tryptophan, 
 
L
 
-kynurenine, picolinic acid (all
from Sigma-Aldrich) and quinolinic acid (Sigma-Aldrich) were
added to the cell cultures at the times and concentrations indicated.
Cocultures of MCSF-treated macrophages and activated PBLs
were performed as described previously (10), with the exception
that we used PHA-activated PBLs as model of T cell activation.
MCSF-treated macrophages to PBLs ratios and monocytes to
PBLs ratios are indicated in the text. MCSF (Vinci-Biochem,
Florence, Italy) was used at a concentration of 200 U/ml. Super-
natants were collected from cocultures 72 h after the addition of
T cells, and levels of kynurenine were measured, as described be-
low. After 24 more hours proliferation was measured.
Cell proliferation was evaluated mainly by standard thymidine
incorporation assay. Unless otherwise indicated, 72 h after cell ac-
tivation 1 
 
 
 
Ci 
 
3
 
[H]thymidine (Amersham Pharmacia Biotech)
was added, and incorporation was measured after 24 h in a
 
 
 
-Counter (Matrix 9600; Canberra Packard). In some tests the
amount of cells in the different phases of the cell cycle was evalu-
ated by exactly following the method of Nicoletti et al. (11).
Flow cytometry analysis was performed on an EPICS XL flow
cytometer (Beckman Coulter), cells were gated on the basis of
physical properties (forward versus side light scatter) and at least
2,000 living cells were analyzed per sample.
 
Tryptophan and Kynurenine Assays.
 
Before the assay, trypto-
phan and kynurenine were extracted from the culture medium
using a previously described technique, with minor changes (12).
In brief, tricloroacetic acid (TCA) was added to the medium at
the final concentration of 0.2 M and the vortexed mixture was
centrifuged 5
 
 
 
 at 13,000 rpm. The pellet was trashed and the su-
pernatant was injected into the HPLC system after its further
centrifugation (5
 
 
 
 at 13,000 rpm).
The HPLC separation was performed at 40
 
 
 
C on a RP col-
umn (Beckman Ultrasphere C18 250 mm length, 2 mm internal
diameter, Alltech Italia srl, Milan, Italy) using bidistilled and fil-
tered water as unique eluent at the flow rate of 0.2 ml/min. The
UV detector was used registering chromatograms at three differ-
ent wavelengths (210, 280, and 360 nm) and collecting spectra in
the 200–450 nm range. In any case, for standards or samples, the
injected volume was of 100 
 
 
 
l and between two successive injec-
tions the delay time was of 25 min. The metabolites of interest
were identified by the use of standards comparing retention times
(9 min for 
 
l
 
-kynurenine and 14 min for 
 
l
 
-tryptophan) and spec-
tra. The real nature of these compounds was confirmed by per-
forming HPLC-mass spectrometric analysis in the negative ion
mode, directly coupling the HPLC eluent to an electrospray ion
source and identifying the analites by the expected m/z ratio. The
quantitative analysis was performed performing two calibration
curves injecting the 
 
l
 
-tryptophan and 
 
l
 
-kynurenine standard
molecules at concentrations between 0.1 and 100 
 
 
 
M.
The sensitivity threshold of the assay was 0.1 
 
 
 
M for both
kynurenine and tryptophan.
RPMI 1640 was found to contain 25 
 
 
 
M tryptophan; addition
of 10% FCS increased tryptophan concentration to 26 
 
 
 
M.
Tryptophan concentration in the above mentioned tryptophan-
free medium was below the sensitivity of the assay.
 
Results
 
Effect of Purified IDO on PBL Proliferation.
 
IDO was pu-
rified according to the protocol described in Materials and
Methods section. The final preparation was homogeneous
by SDS-PAGE and HPLC. The overall purification was
480-folds and the specific activity was of 156,000 U/mg
of protein.
The capacity of the purified enzyme to inhibit PBL pro-
liferation was tested by adding the enzyme at increasing
concentrations at the beginning of the test, together with
methylene blue and 
 
L
 
-ascorbic acid. These cofactors were
added to optimize the efficiency of the enzyme, possibly by
increasing production of O
 
2
 
 
 
 (13). Under these conditions a
dose-dependent inhibition of cell proliferation was detected,
both by evaluating 
 
3
 
[H]thymidine incorporation (Fig. 1 A)
and by counting the cells entering the cell cycle (Fig. 1 B).
The role of cofactors is elucidated in Fig. 2, showing the
effect of various combinations of IDO and cofactors on the
proliferation of PHA-stimulated PBLs, evaluated both by
measuring 
 
3
 
[H]thymidine incorporation (Fig. 2 A) and by
counting the cells entering the cell cycle (Fig. 2 B). When
the sole IDO, at the final concentration of 4,000 U/ml,
was added at the beginning of the test, half of proliferation
was retained. The same result was obtained by adding to
IDO either methylene blue or 
 
L
 
-ascorbic acid. Instead, co-
incubation of IDO with both cofactors reduced prolifera- 
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tion to one fourth of the control. The same result was ob-
tained when 800 U IDO/well were added daily to the
culture, in the absence of cofactors.
To reach the confirmation that the inhibition of PBL
proliferation was due solely to the enzymatic activity of
IDO, inhibition tests were performed in the presence of 1
mM 1-methyl-DL-tryptophan, a compound reported to be
a potent inhibitor of IDO activity (14). As shown in Fig. 3,
A and B, 1-methyl-DL-tryptophan was able to almost
completely prevent the inhibition of proliferation induced
by IDO and cofactors.
On the basis of previous studies, indicating that mac-
rophage-dependent inhibition of T cell proliferation could
be related to a sustained arrest of the cell cycle in the mid-
G1 phase (6), we checked whether PBLs activated with
PHA in the presence of IDO showed an arrest in cell cycle
progression. Indeed, by counting the cells in the different
phases of the cell cycle with the method of Nicoletti et al.
(11), we found that PHA-activated PBLs in the presence of
IDO showed a marked reduction in the number of cells in
the phases from S to M (Fig. 1 B).
 
Effect of Tryptophan and of Its Catabolites on PBL Prolifera-
tion.
 
Tryptophan is converted by IDO to 
 
N
 
-for-
mylkynurenine; this substance is further catabolized to
kynurenine and then to the terminal metabolites picolinic
acid or quinolinic acid. To understand the mechanisms of
the inhibitory effect of the enzyme on PBL proliferation, it
is mandatory to elucidate the effects that reduction of tryp-
tophan and/or increase of downstream catabolites in the
medium have on cell proliferation. Therefore, we started to
investigate the effects exerted on PBL proliferation by three
Figure 1. Dose–response relationship to IDO for T cell proliferation.
Increasing doses of IDO, together with 0.1  M methylene blue and 200
 M L-ascorbic acid, were added at the beginning of the test to PHA-acti-
vated PBLs. Untreated cells were used as control. Cell culture was
stopped at 96 h and proliferation was evaluated by measuring 3[H]thymi-
dine incorporation (A) or by counting the cells in the cell cycle, as indi-
cated in the Materials and Methods section (B). m   1 SD, n   3.
Figure 2. Role of cofactors on IDO activity. PHA-activated PBLs
were incubated with the indicated combinations of 4,000 U/ml IDO, 0.1
 M methylene blue, and 200  M L-ascorbic acid. In a set of experiments
800 U IDO were added daily to the cell culture, in the absence of cofac-
tors. Control is represented by cells incubated with medium alone. Cell
culture was stopped after 96 h and proliferation was evaluated by measur-
ing 3[H]thymidine incorporation (A) or by counting the cells in the cell
cycle (B). m   1 SD, n   3.
Figure 3. Effect of the IDO competitive inhibitor 1-methyl-DL-tryp-
tophan. PHA-activated PBLs were incubated with the indicated combi-
nations of 4,000 U/ml IDO, 0.1  M methylene blue, 200  M L-ascor-
bic acid, and 1 mM 1-methyl-DL-tryptophan. Control is represented by
cells incubated with medium alone. Cell culture was stopped after 96 h
and proliferation was evaluated by measuring 3[H]thymidine incorpora-
tion (A) or by counting the cells in the cell cycle (B). m   1 SD, n   3.463 Frumento et al.
tryptophan-derived catabolites: L-kynurenine, picolinic acid,
and quinolinic acid. The test was performed in complete
culture medium, that contains 26  M tryptophan, and the
substances were added at the beginning of the test (Fig. 4
A). At concentrations above 1 mM a toxic effect was de-
tected for all the three substances. Below this threshold, a
dose-dependent inhibition of proliferation was observed
with  L-kynurenine and, to a lesser extent, with picolinic
acid; instead, quinolinic acid was ineffective. Upon coincu-
bation, l-kynurenine and picolinic acid showed a clear syn-
ergistic effect (Fig. 4 B). The two substances exerted their
effect by blocking cell cycle in the mid-G1 phase (Fig. 4 C).
To further investigate the characteristics of this inhibi-
tory effect, we focused our attention on l-kynurenine that
was the most effective, among the tryptophan-derived
catabolites examined, in inhibiting cell proliferation. The
results of this investigation are summarized in Fig. 5. As it
Figure 4. Effect of tryptophan catabolites on T cell proliferation. (A)
Increasing concentrations of L-kynurenine ( –– ), picolinic acid ( - - -
 ), or quinolinic acid ( ..... ) were added to PHA-activated PBLs. Cell
culture was stopped after 96 h and proliferation was evaluated by measur-
ing  3[H]thymidine incorporation. (B) PHA-activated PBLs were incu-
bated with the indicated combinations of 250  M  L-kynurenine, pi-
colinic acid, or quinolinic acid. Control is represented by cells incubated
with medium alone. Cell culture was stopped after 96 h and proliferation
was evaluated by measuring 3[H]thymidine incorporation. (C) PHA-acti-
vated PBLs were incubated with 250  M of L-kynurenine, picolinic acid,
or quinolinic acid, respectively. Control is represented by untreated
PHA-blasts. Cell culture was stopped after 96 h and the cells in the cell
cycle were counted. m   1 SD, n   3.
Figure 5. Timing of L-kynurenine–dependent inhibition of T cell pro-
liferation.  L-kynurenine at 1 mM concentration (top) or at 500  M
(bottom) was added to PHA-activated PBLs at the beginning of the test,
or 18, 24 or 36 h after PHA activation, timing of L-kynurenine adminis-
tration being indicated in the left column. In a subset of experiments
L-kynurenine, administered at the beginning of the test, was removed
from the samples at the times indicated in the central column: samples
were centrifuged, supernatant was discarded, and cells were resuspended
in medium. In a further subset of experiments PHA was administered
again to the cells immediately after L-kynurenine wash-out (right col-
umn). Control is represented by untreated PHA-activated PBLs. Cell cul-
ture was stopped after 96 h from PHA activation, and proliferation was
evaluated by measuring 3[H]thymidine incorporation. The degree of pro-
liferation is indicated by the bars in the right part of each panel. The dotted
line shows thymidine incorporation of control. m   1 SD, n   3.464 Tryptophan-derived Catabolites Inhibit Cell Proliferation
can be seen, both 0.5 and 1 mM L-kynurenine abrogated
proliferation when administered till 36 h after activation.
Inhibition with 1 mM L-kynurenine could not be reverted
by washing out the substance or by restimulating the cells
after wash-out. Instead, when 0.5 mM L-kynurenine was
used, cell proliferation was restored either partially or com-
pletely by washing out the substance, the amount of recov-
ery being inversely related to the length of incubation with
L-kynurenine; the amount of recovery was not signifi-
cantly increased by restimulating the cells with PHA after
wash-out.
It has to be noted that exogenously added L-kynurenine
is degraded during incubation with PBLs. In the case of
100  M L-kynurenine added at the beginnning of the test
to PHA-activated PBLs, a residual concentration of 25  M
L-kynurenine could be detected 72 h later.
To evaluate the relevance of the tryptophan levels in the
extracellular environment, we used a culture medium de-
void of tryptophan. As shown in Fig. 6 A, PHA-activated
PBLs retained the capacity to proliferate in this medium.
Furthermore, proliferation was not increased by adding in-
creasing concentrations of L-tryptophan at the beginning of
the test. In particular, no increase in proliferation was ob-
served after adding 30  M L-tryptophan, that is above the
concentration of tryptophan in the normal culture me-
dium. Afterward, the degree of inhibition of PBL prolifera-
tion was evaluated for each of the three catabolites both in
tryptophan-free medium and in tryptophan-free medium
supplemented with 26  M L-tryptophan, that is the con-
centration of tryptophan in normal complete medium (Fig.
6, B–D). In the absence of tryptophan, L-kynurenine and,
to a lesser extent, picolinic acid were endowed with inhib-
itory activity at concentrations that were below the con-
centrations that inhibited PBL proliferation in the presence
of the amino acid (Fig. 6, B and C). Quinolinic acid, that
was ineffective in the presence of L-tryptophan, in the ab-
sence of tryptophan showed a dose–response relationship
for inhibition of proliferation (Fig. 6 D).
The next step was aimed at comparing the effect of ex-
ogenously added L-kynurenine with the effect displayed by
kynurenine produced as consequence of IDO expression in
MCSF-treated macrophages upon incubation with acti-
vated PBLs. Cocultures of the two cell populations were
performed, and kynurenine was measured in supernatants.
Accordingly to previous data (10), different degrees of inhi-
bition of PBL proliferation could be observed, depending
on the macrophages to PBLs ratio (Fig. 7 A). Instead, un-
treated monocytes did not affect PBL proliferation. After-
ward, the amount of kynurenine in the supernatant of co-
cultures at different macrophages to PBLs ratios was
measured, and related to the degree of cell proliferation. A
clear inverse relationship was found (Fig. 7 B). In this
model substantial inhibition of proliferation was achieved
with concentrations of kynurenine at 72 h above 10  M.
T Lymphocytes and NK Cells Are the Targets of IDO-depen-
dent Inhibition. Since PBLs are made up of different sub-
populations, we wanted to get some insight into the sen-
sitivity of each subpopulation to IDO activity. For this
reason IDO effect was tested on CD4  and on CD8  T
lymphocytes, on B lymphocytes, and on NK cells purified
from peripheral blood (Fig. 8 A). We found that IDO-
dependent inhibition of proliferation only applies to T lym-
phocytes and NK cells responding to a proliferative stimu-
lus, proliferation of B lymphocytes not being affected. As in
the case of PBLs, proliferation of each subpopulation in
tryptophan-free medium did not differ from proliferation
Figure 6. Effect of tryptophan concentration on
tryptophan catabolites-dependent inhibition of T cell
proliferation. (A) Increasing concentrations of L-tryp-
tophan were added to PBLs activated and cultured in a
medium devoid of tryptophan. Cell culture was
stopped after 96 h from PHA activation, and prolifera-
tion was evaluated by measuring 3[H]thymidine incorpo-
ration. (B–D) Increasing concentrations of L-kynurenine
(B), picolinic acid (C), and quinolinic acid (D) were
added to PBLs activated and cultured in tryptophan-
free medium ( —— ), or in the tryptophan-free
medium supplemented with 26  M  L-tryptophan
( —— ). Controls were represented by untreated
PHA-activated PBLs grown in tryptophan-free medium
and in the same medium supplemented with L-tryp-
tophan, respectively. Cell culture was stopped after 96 h
from PHA activation, and proliferation was evaluated
by measuring 3[H]thymidine incorporation. To permit
comparison, proliferation has been normalized to the
control cultures (PHA-activated PBLs grown in tryp-
tophan-free medium: 19,134   1,109 cpm; PHA-acti-
vated PBLs grown in tryptophan-free medium supple-
mented with L-tryptophan: 20,021   1,776 cpm). m  
1 SD, n   3.465 Frumento et al.
in the same medium supplemented with 26  M tryp-
tophan (proliferation in tryptophan-supplemented medium
being 83.4   9.7% of proliferation in tryptophan-free me-
dium for CD4  T lymphocytes, 114.1   11.5% for CD8 
T lymphocytes, 108.7   10.3 for B lymphocytes, and
81.3   14.8 for NK cells; m   1 SD, n   3). Instead, tryp-
tophan-derived catabolites were effective, in the IDO-sen-
sitive subpopulations, in inhibiting cell proliferation (Fig. 8,
B–D), Consistent with the findings from PBLs, the inhibi-
tory activity was enhanced in the absence of tryptophan.
Inhibition of Cell Proliferation only Applies to Cells Respond-
ing to a Stimulus. We noted in the experiments showed in
Fig. 5 that cell proliferation could be irreversibly affected
by  L-kynurenine. This finding allowed us to address the
question on whether IDO-dependent inhibition only ap-
plies to cells responding to a stimulus, or to all the cells in
the culture, both activated and resting. MLRs were initially
performed either in the presence or in the absence of
L-kynurenine. 5 d after cells were washed to remove the
catabolite and cultures were then restimulated with either
cells from the initial stimulator or from a different donor.
Figure 7. Relationship between degree of proliferation and concentra-
tion of kynurenine in coculture supernatants. (A) PHA-activated PBLs
(PHA blasts) were cultured alone, in the presence of monocytes at the ra-
tios indicated, in the presence of MCSF-treated macrophages at the ratios
indicated, or in the presence of the MCSF solution (200 U/ml) used with
macrophages. Cell culture was stopped after 96 h from PHA activation,
and proliferation was evaluated by measuring 3[H] thymidine incorpora-
tion. m   1CD, n   3. (B) PHA-activated PBLs were cultured in the
presence of MCSF-treated macrophages at ratios of 4:1 ( ), 16:1 ( ),
64:1( ), each ratio being performed in triplicate. Supernatants were
collected from cocultures 72 h after the addition of PBLs, and levels of
kynurenine were measured, as described in Materials and Methods sec-
tion. Cell culture was stopped after 24 more hours, and proliferation was
evaluated by measuring 3[H]thymidine incorporation. The amount of
kynurenine in each supernatant was related to the level of proliferation in
the well. The regression line is indicated. Star indicates the mean of thy-
midine incorporation of three wells with PHA-activated PBLs alone.
Figure 8. Effect of IDO and tryptophan-derived catabolites on differ-
ent PBL subpopulations. (A) The different cell subpopulations were acti-
vated as indicated in the Materials and Methods section, and cultured in
the presence of 4,000 U/ml IDO, 0.1  M methylene blue, and 200  M
L-ascorbic acid. Cell culture was stopped after 96 h from activation, and
proliferation was evaluated by measuring 3[H]thymidine incorporation.
For each subpopulation untreated activated cells were used as control.
m   1 SD, n   3. (B–D) The effect of 1 mM L-kynurenine (B), 1 mM
picolinic acid (C), and 1 mM quinolinic acid (D) was tested on each PBL
subpopulation. The different cell subpopulations were activated as indi-
cated in the Materials and Methods section, and cultured either in tryp-
tophan-free medium (white columns), or in tryptophan-free medium
supplemented with 26  M L-tryptophan (black columns). Cell culture
was stopped after 96 h from activation, and proliferation was evaluated by
measuring  3[H]thymidine incorporation. For each subpopulation un-
treated cells, activated and cultured in the same medium, were used as
control. m   1 SD, n   3.466 Tryptophan-derived Catabolites Inhibit Cell Proliferation
After 7 more days cell proliferation was measured. Results
are shown in Fig. 9. Responsiveness to the original donor
was dramatically reduced in cells pretreated with L-kynure-
nine, as compared with untreated cells. Instead, responsive-
ness of the same cells to the new donor was not affected.
This finding indicates that L-kynurenine-dependent
block is specific to cells responding to an activating stimu-
lus; resting cells remain viable, and can subsequently acti-
vate normally.
Discussion
In this study, we have investigated the mechanisms of
IDO-dependent inhibition of PBL proliferation. For this
purpose we have set up a new protocol for IDO purifica-
tion. Our approach allows the same recovery, but is both
easier and faster than the ones described previously (7, 9).
Afterward, we tested the capacity of purified IDO to in-
hibit PBL proliferation in in vitro models. We have used
PHA as mitogen, instead of anti-CD3 (6, 10), to avoid any
possible interference via Fc receptors, that are highly ex-
pressed on macrophage surface (15). The other model we
used was based on alloreactive T cell lines. The two models
gave equivalent results, but for brevity only results with
PHA-activated PBLs are shown here.
In detail, we found that purified IDO at a concentration
of 4,000 U/ml was able to reduce proliferation of PBLs to
the half, when administered at the beginning of the test.
However, because of the short half-life of the enzyme at
37 C in culture medium (unpublished data and reference
16), purified IDO was more effective when administered
repeatedly than in a single dose. Better results were ob-
tained by coincubating the enzyme with methylene blue
and L-ascorbic acid: these cofactors optimize the efficiency
of the enzyme, possibly by increasing production of O2
 
(13). It is possible that cofactors exist in macrophage cyto-
sol that perform the same function of the two above men-
tioned substances. We got a confirmation that the inhibi-
tion of PBL proliferation was due to the enzymatic activity
of IDO by demonstrating that 1-methyl-DL-tryptophan, a
competitive inhibitor of IDO activity (14), was able to al-
most completely prevent the inhibition of proliferation in-
duced by the enzyme.
In agreement with previous studies (6), indicating that
macrophage-dependent inhibition of T cell proliferation
was related to a sustained arrest of the cell cycle, we found
that also IDO treatment blocks cells in the mid-G1 phase.
These data, taken together, suggest that macrophage-
dependent inhibition of PBL proliferation can result from
the sole IDO enzymatic activity, and other antiproliferative
factors released by macrophages might be not required.
We also found that, among the different subpopulations
making up PBLs, only CD4  and CD8  T lymphocytes
and NK cells were sensitive to IDO, proliferation of B lym-
phocytes not being affected. This finding, together with
previous data indicating that proliferation of fibroblasts and
of vascular endothelial cells is not affected by the presence
of macrophages (10), rules out the possibility that IDO
might act as a nonspecific inhibitor for proliferating cells.
Instead, inhibition of cell proliferation induced by the
tryptophan catabolites resulting from IDO activity is selec-
tive, applying to specific leukocyte subpopulations and only
to cells undergoing activation. Resting cells are not affected
and can subsequently activate normally.
Previous data show that both macrophages (6) and den-
dritic cells (17) can inhibit T cell proliferation via IDO-
dependent mechanisms. Our results confirm the immuno-
logical role played by the enzyme.
In this regard, it has been hypothesized that IDO expres-
sion by APCs helps maintain peripheral tolerance by regu-
lating autoreactive T cells that have escaped intrathymic
deletion (6, 10). It has also been suggested that IDO
production by APCs could be part of a mechanism self-lim-
iting immune response (17). As a matter of fact, IDO ex-
pression is induced in APCs by signals, namely IFN-  and
CD40 ligand, produced by T cells undergoing activation.
Therefore, IDO might be part of a negative feedback loop.
To gain insights into the mechanisms of IDO-dependent
inhibition of T and NK cell proliferation, we analyzed the
effects of changes in the concentration of tryptophan and its
catabolites in the extracellular microenvironment. We found
that in the absence of tryptophan substantial levels of prolif-
eration were retained. It is conceivable that cells could get
the tryptophan that is required for proliferation by cataboliz-
ing proteins contained in the medium. The slight reduction
in cell proliferation that was observed under these conditions
could not be related to the lack of tryptophan, since addition
of L-tryptophan did not increase proliferation. Instead, we
think that part of factors sustaining proliferation, that are
normally contained in FCS, were probably lost during the
dialysis performed to remove unbound tryptophan.
The three tryptophan-derived catabolites we tested were
found to be able, at various degree and under different
Figure 9. Effect of L-kynurenine on responsiveness of activated and
resting cells. MLRs were initially performed either in the presence
(white columns and black columns) or in the absence (gray columns) of
L-kynurenine. 5 d after cells were washed and cultures were then restim-
ulated with either cells from the initial stimulator (white columns) or
from a different donor (black columns). After 7 more days cell prolifera-
tion was evaluated by measuring 3[H]thymidine incorporation. Three ex-
periments, using different responders and stimulators were performed.
Each column indicates the mean from three wells.467 Frumento et al.
conditions, to inhibit cell proliferation. In the presence of
tryptophan, inhibition of proliferation was observed with
L-kynurenine and, to a lesser extent, with picolinic acid;
instead, quinolinic acid was ineffective. When the same test
was performed in the absence of thryptophan, all the three
catabolites were effective, at various degrees, in inducing a
dose-dependent inhibition of proliferation. In the case of
L-kynurenine and, to a lesser extent, of picolinic acid, inhi-
bition was observed at concentrations below the lowest
concentration that was effective in the presence of tryp-
tophan, while in the case of quinolinic acid the inhibitory
capacity was acquired de novo.
Confirming their role as major cause of IDO effect, tryp-
tophan-derived catabolites were found to exert their inhib-
itory effect by blocking the cell cycle progression.
It has to be noted that at concentrations of L-kynurenine
up to 500  M the inhibition of PBL proliferation occurs
only when the substance is added within 36 h from cell ac-
tivation and inhibition can be overcome by removing the
substance from the medium within the same period. This
indicates that the target mechanisms of L-kynurenine-
dependent inhibition are operative only at the early stages
of cell activation. This finding is in agreement with data
from (10), indicating that macrophage-dependent suppres-
sion of T cell proliferation specifically affects the initial
transition from quiescence to proliferation.
Some considerations can also be done on the results of
the attempt to compare the effect of exogenously added
L-kynurenine with the effect displayed by kynurenine result-
ing from IDO expression by MCSF-treated macrophages
in the presence of activated PBLs. Cocultures were per-
formed, and kynurenine levels in the supernatants were re-
lated to the degree of inhibition observed. Confirming the
role of kynurenine in IDO-dependent inhibition of cell
proliferation, the amount of kynurenine in the supernatant
was inversely related to the degree of cell proliferation (Fig.
7 B). We are well aware of the fact that we do not know
the kinetics of release and consumption of kynurenine in
cocultures of MCSF-treated macrophages and activated
PBLs, therefore a precise comparison of the activity of
kynurenine in the two systems cannot be done. However,
it is noteworthy that the range of concentration of kynure-
nine that in this system is related with reduced cell prolifer-
ation is close to the range of concentration of exogenous
L-kynurenine that is active in tryptophan-free medium in the
absence of MCSF-treated macrophages. As a matter of fact,
we found that in cocultures of MCSF-treated macrophages
and activated PBLs, proliferation  50% was achieved with
concentrations of L-kynurenine at 72 h below 10  M. A
degree of proliferation in the range of 50% of control was
achieved in tryptophan-free medium in the absence of
MCSF-treated macrophages by exogenously adding L-kyn-
urenine at concentrations between 200 and 40  M at the
beginning of the test. Since L-kynurenine is quickly de-
graded in the supernatant of PBL cultures, it is conceivable
that the concentration that is effective during the test is
well below the concentration at the beginning of the test.
We have to take into account also the probable occur-
rence of synergic effect of different tryptophan-derived
catabolites, as in the case of L-kynurenine and picolinic
acid.
These considerations prompt us to suggest that L-kyn-
urenine and, possibly, also other tryptophan-derived catab-
olites are the substances responsible for the inhibitory effect
displayed by the enzyme on proliferation of IDO-sensitive
cells. Our data indicate in tryptophan-derived catabolites a
group of substances endowed with immunosuppressive ac-
tivity.
These conclusions are in contrast with previous findings
from D.H. Munn and coworkers, indicating that the inhib-
itory effect exerted by IDO on T cell proliferation can be
due to the sole tryptophan starvation (6). The authors reach
their conclusions on the basis of the fact that conditioned
medium from cocultures of MCSF-treated macrophages
and activated T cells was unable to support T cell prolifera-
tion unless tryptophan was added. However, in the light of
our results, the data displayed by Munn and coworkers do
not rule out the possibility of tryptophan-derived immuno-
suppressive catabolites. As a matter of fact, we have found
kynurenine in the supernatant of cocultures performed as
described by Munn and coworkers. Therefore, we suggest
that this substance, and presumably other tryptophan-
derived catabolites in the conditioned medium, was respon-
sible of the inhibitory effect on T cell proliferation displayed
by conditioned medium in (6) Also, the capacity of the
same conditioned medium to support T cell proliferation
after the addition of tryptophan could be explained on the
basis of our results. To exert the same inhibitory effect, L-kyn-
urenine has to be one order of magnitude more concentrate
in the presence of tryptophan than in the absence of the
amino acid. As it regards the experiment described in (6),
we suggest that after tryptophan was added the concentra-
tion of kynurenine in the conditioned medium was not
able anymore to inhibit T cell proliferation.
Instead, we speculate that IDO expressed by macro-
phages upon interaction with activated T cells exerts its ef-
fect on T and NK cell proliferation via two different
mechanisms. On one side it starts the cascade of biochem-
ical reactions that leads to the production of tryptophan-
derived catabolites, themselves endowed with the capacity
to inhibit cell proliferation. On the other side it depletes
the medium of tryptophan, allowing at least three catabo-
lites to put in action their inhibitory potential at concen-
trations that probably can be achieved in the extracellular
microenvironment.
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